MSP's Citylabs Campus Expansion


Citylabs is the only development of its kind in the UK, based on a joint venture partnership between Manchester Science Partnerships (MSP) - the UK's leading science and technology park operator, and Manchester University NHS Foundation Trust (MFT) - the UK's largest NHS provider Trust.

Hear about the vision for MSP's Citylabs Campus from Managing Director,
Tom Renn:

The next phase for Citylabs is a £60m, 220,000 sq ft expansion to create Citylabs 2.0 & 3.0 within MFT's hospital campus. Citylabs 2.0 & 3.0 will be immediately surrounded by the Manchester Royal Infirmary, Royal Manchester Children's Hospital, Manchester Royal Eye Hospital, and Saint Mary's Hospital.

Citylabs 2.0 & 3.0 will become a national hub for precision medicine and data analytical businesses, to accelerate innovation in these sectors and adopt them within patient care at pace and scale through collaboration.

Having celebrated the Citylabs 2.0 Topping Out Ceremony in September 2019, hear from Sir Robert Mcalpine's Project Manager, Gary Lewis about the Citylabs 2.0 development:

Following high levels of demand, MSP and Manchester University NHS Foundation Trust (MFT) have recently unveiled plans to develop Citylabs 4.0, a new £35 million development which will grow the existing Citylabs campus by 125,000 sq ft.

The new development represents another step forward for Manchester’s Oxford Road Corridor innovation district, Europe’s largest clinical academic campus and one of the North of England’s most important commercial areas, generating around £3bn in GVA each year.

About the Citylabs campus

Located within Europe’s largest clinical-academic campus, Citylabs 2.0 is surrounded by the Manchester Royal Infirmary, Royal Manchester Children’s Hospital, Saint Mary’s Hospital and Manchester Royal Eye Hospital and will build on the success of Citylabs 1.0 which has been fully let since its completion in 2015 and has already showcased a unique new way of collaborative working between industry, academia and clinicians.

Manchester’s new genomics campus will create more than 1,500 high value jobs over the next decade, adding over £150m to the city region’s economy. Crucially, it will positively impact the lives of over three million people by providing access to new diagnostics and more targeted treatments through pioneering research, and will see these products and services adopted into the city’s health service at a much faster rate. 

Citylabs 1.0 is home to pioneering businesses working across the life sciences and medtech sector. Hear from MSP's customer Takagi about why the team have benefited from being located at Citylabs 1.0: